Literature DB >> 7548812

Barrett's oesophagus and Helicobacter pylori.

Z Abbas1, A S Hussainy, F Ibrahim, S M Jafri, H Shaikh, A H Khan.   

Abstract

In order to demonstrate the presence of Helicobacter pylori in the metaplastic epithelium of Barrett's oesophagus and to evaluate its possible association with this entity, we examined 29 cases of Barrett's oesophagus where concomitant antral biopsies were also available. These cases were compared with an equal number of age and sex matched controls of uncomplicated reflux oesophagitis. H. pylori was present in 11 of 29 cases of Barrett's oesophagus (38%). No increase in the frequency of H. pylori antral gastritis was found in patients of Barrett's oesophagus compared to the control group of uncomplicated reflux oesophagitis. The positivity of Barrett's oesophagus for H. pylori correlated with the presence of H. pylori antral gastritis (P < 0.05), although in two cases of H. pylori-positive Barrett's oesophagus antral biopsies were negative for H. pylori. No difference was found in the severity of inflammatory and dysplastic changes of H. pylori-positive and H. pylori-negative Barrett's oesophagus. Presence of H. pylori does not seem to alter the natural history of Barrett's oesophagus.

Entities:  

Mesh:

Year:  1995        PMID: 7548812     DOI: 10.1111/j.1440-1746.1995.tb01102.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First).

Authors:  Sri Ganeshamurthy Thrumurthy; Christopher John Lewis; Susan Pritchard; Gordon Armstrong; Stephen Edwin Arthur Attwood
Journal:  Surg Endosc       Date:  2012-01       Impact factor: 4.584

Review 3.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

4.  Utility of endoscopy for diagnosis of barrett in a non-Western society: endoscopic and histopathologic correlation.

Authors:  Bahadır Ege; Tolga Dinç; Baris D Yildiz; Zeynep Balci; Hakan Bozkaya
Journal:  Int Surg       Date:  2015-01-14

5.  Examination of tissue distribution of Helicobacter pylori within columnar-lined esophagus.

Authors:  V K Sharma; S E Demian; D Taillon; R Vasudeva; C W Howden
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

6.  The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis.

Authors:  Lori A Fischbach; Helena Nordenstedt; Jennifer R Kramer; Subi Gandhi; Sam Dick-Onuoha; Anthony Lewis; Hashem B El-Serag
Journal:  Helicobacter       Date:  2012-03-20       Impact factor: 5.753

7.  Relationship of gastric Helicobacter pylori infection to Barrett's esophagus and gastro-esophageal reflux disease in Chinese.

Authors:  Jun Zhang; Xiao-Li Chen; Kang-Min Wang; Xiao-Dan Guo; Ai-Li Zuo; Jun Gong
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

8.  Prevalence of Barrett's esophagus in Northern Greece: A Prospective Study (Barrett's esophagus).

Authors:  P Katsinelos; G Lazaraki; J Kountouras; G Chatzimavroudis; C Zavos; S Terzoudis; E Tsiaousi; S Gkagkalis; C Trakatelli; A Bellou; T Vasiliadis
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

Review 9.  Does Helicobacter pylori infection contribute to gastroesophageal reflux disease?

Authors:  S J Spechler
Journal:  Yale J Biol Med       Date:  1998 Mar-Apr

Review 10.  Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review.

Authors:  Bálint Erőss; Nelli Farkas; Áron Vincze; Benedek Tinusz; László Szapáry; András Garami; Márta Balaskó; Patrícia Sarlós; László Czopf; Hussain Alizadeh; Zoltán Rakonczay; Tamás Habon; Péter Hegyi
Journal:  Helicobacter       Date:  2018-06-25       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.